Ignite Creation Date:
2024-05-05 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00190437
Status:
COMPLETED
Last Update Posted:
2011-05-02
First Post:
2005-09-15
Brief Title:
ANTEAB a Study of Early Antibiotherapy in the ICU Management of Acute Exacerbations of COPD
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Assistance Publique - Hôpitaux de Paris
Study Overview
Official Title:
ANTEAB a Study of Early Antibiotherapy in the ICU Management of Acute Exacerbations of COPD
Status:
COMPLETED
Status Verified Date:
2007-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Intensive Care Unit ICU admission for acute exacerbation of chronic obstructive lung disease COLD is a major cause of morbidity and mortality in such patients Although bacterial of mortality in such patients Although bacterial and or viral infections are considered as the major precipitating factor the antibiotic strategy in this setting is unclear The absence of overt infection remains controversial and has not been adequately studied in patients admitted to the ICU To assess the benefit or lack thereof of routine early systemic antibiotic therapy in patients with COLD admitted to the ICU
The primary objective of the essay is to evaluate the effectiveness of the precocious antibiotic therapy on the length of the respiratory symptoms with the admitted patients in polyvalent medical intensive care of chronic obstructive lung disease COLD
The primary objective of the essay is to evaluate the effectiveness of the precocious antibiotic therapy on the length of the respiratory symptoms with the admitted patients in polyvalent medical intensive care of chronic obstructive lung disease COLD
Detailed Description:
This is a multicenter randomised double-blind controlled trial comparing amoxicillin-clavulanic acid administered for 7 days to a placebo
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None